Main Menu

List of studentship projects

Applications are now closed for the following PhD studentships.

Each is fully-funded for four years, with expected commencement in October 2018.

Please click the complete project proposal links below for full details about available projects and the supervisory team. Projects marked with an * have additional eligibility criteria, details of which can be found on the section project lists on the right.

Read our Application Information page to see full eligibility criteria and complete the online application form.

  • The closing date was 9pm on Monday 20 November 2017.
  • Applicants should be available for interview 29 and 30 January 2018.


Division of Clinical Studies

  • Primary supervisor: Professor Emma Hall
  • Project: Dynamic prediction statistical models to characterise localised prostate cancer prognosis
  • Menu title: Dynamic prediction statistical models in prostate cancer

View complete project proposal

  • Primary supervisor: Dr Udai Banerji
  • Project: The role of cancer associated fibroblasts in altering signal transduction and drug resistance in KRAS mutated cancers
  • Menu title: Cancer associated fibroblasts in KRAS mutated cancers

View complete project proposal

  • Primary supervisor: Dr Maggie Cheang
  • Project: Identification of biomarkers to predict response for emerging therapeutic agents for triple negative breast cancer
  • Menu title: Response biomarkers in TNBC

View complete project proposal

 

Division of Breast Cancer Research

View complete project proposal

  • Primary supervisor: Dr Olivia Fletcher
  • Project: Capture Hi-C approach to discovering somatic mutations in long-range regulatory elements of breast cancer genes
  • Menu title: Using Capture Hi-C for breast cancer mutations

View complete project proposal

 

Division of Cancer Biology

  • Primary supervisor: Dr Jyoti Choudhary
  • Project: Characterisation of function and regulation of translation elongation factor eEF2 and its role in oncogenesis
  • Menu title: eEF2 characterisation by proteomic mass spectrometry

View complete project proposal

  • Primary supervisors: Dr Wojciech Niedzwiedz and Dr Alessandro Vannini
  • Project: Structures and mechanisms of EXD2 nuclease in DNA repair
  • Menu title: EXD2 nuclease in DNA repair

View complete project proposal

  • Primary supervisor: Dr Chris Bakal
  • Project: How physical constraints on lung cancer cells fuel their evolution.
  • Menu title: Physical contraints on lung cancer cells

View complete project proposal

 

Division of Cancer Therapeutics

  • Primary supervisors: Professor Rajesh Chopra and Dr Jyoti Choudhary
  • Project: Defining the place of the CRL4 substrate receptors (DCAFs) in NSCLC for the discovery of novel targets and small molecule modulators
  • Menu title: DCAFs in NSCLC

View complete project proposal

View complete project proposal

  • Primary supervisor: Dr Swen Hoelder
  • Project: Exploring bifunctional degrader libraries for the discovery of new cancer targets
  • Menu title: Design and synthesis of bifunctional degraders

View complete project proposal

  • Primary supervisor: Dr Rob van Montfort
  • PrInvestigating inhibitor binding with cryo-EMoject
  • Menu title: Investigating inhibitor binding to cancer targets using cryo-EM

View complete project proposal

 

National Institute of Health Research Biomedical Research Centre

These are clinically focused projects supporting the translational work of the NIHR Biomedical Research Centre at the Royal Marsden and the Institute of Cancer Research. 

  • Primary supervisor: Professor Mitch Dowsett and Dr Robyn Shea
  • Project: Dried Blood Spot Analysis of Heavy/light and Free Light Chains to improve the patient pathway for Myeloma Patients
  • Menu title: Dried blood spot analysis in myeloma

View complete project proposal

  • Primary supervisor: Dr Mike Hubank
  • Project: Liquid biopsy to monitor clonal frequency and emergence of resistance mutations in common drivers of paediatric cancers
  • Menu title: Liquid biopsy monitoring of paediatric cancer drivers

View complete project proposal

  • Primary supervisor: Dr Marco Gerlinger
  • Project: Deciphering and targeting of novel immune evasion mechanisms in patient derived gastrointestinal cancer models
  • Menu title: Immune evasion mechanisms in GI cancer models

View complete project proposal

 

The Cancer Research Centre of Excellence

The Cancer Research Centre of Excellence (CRCE) is a strategic partnership between Imperial College London and The Institute of Cancer Research. All projects are jointly supervised. Please note that  the funding covers course fees at the Home/EU rates and funding for overseas fees is not provided.

 The ICR Registered

  • Supervisors: Dr Emma Harris (ICR) and Dr Peter Huthwaite (Imperial)
  • Project: Ultrasound backscatter assessment of tumour response to radiotherapy using finite element model-based attenuation and diffraction corrections*
  • Menu title: Ultrasound backscatter assessment of radiotherapy response

View complete project proposal

  • Supervisors: Professor Gail ter Haar (ICR) and Dr James J Choi (Imperial)
  • Project: Ultrasound drug delivery across the blood-brain barrier for the treatment of paediatric brain cancer*
  • Menu title: Ultrasound drug delivery across the BBB in paediatric brain cancer

View complete project proposal

Imperial College registered:
 

 Please note these are listed for information. Application for these studentships is directly via Imperial.

  • Supervisors: Professor Molly Stevens (Imperial) and Dr Chris Bakal (ICR)
  • Project: Nanotopographical effects on transcriptional regulation and nuclear morphology to inform strategies against cancer*

Please visit Imperial College for more information on this project.

Please visit Imperial College for more information on this project.

MRC industrial CASE (iCASE) studentships in Enabling Integrated Drug Discovery

This programme offers an opportunity to train as a researcher with exposure to and understanding of integrated interdisciplinary drug discovery in both academia and industry. 

Three studentships are in collaboration with either AstraZeneca or Merck. Please note specific eligibility criteria apply.

There are three studentships available.

In collaboration with AstraZeneca: 

  • Primary supervisor:  Dr Swen Hoelder
  • Project: Activating and directing post-translational modification by the design and synthesis of heterobifunctional small molecules*   
  • Menu title: Small molecule activators of post-translational modification

View complete project proposal

  • Primary supervisor:  Dr Wojciech Niedzwiedz 
  • Project: Elucidating the molecular mechanism of DNA-end resection and its role in the Double-Strand-Break (DSB) repair pathway choice*
  • Menu title: Molecular mechanisms of DSB pathway choice

View complete project proposal

In collaboration with Merck:

  • Primary supervisor: Dr Sebastian Guettler and Professor Chris Lord
  • Project: A genetic approach to studying tankyrase regulation and function*
  • Menu title: Genetic approach to tankyrase regulation & function

View complete project proposal

Key information

Read our Application Information page to see full eligibility criteria and complete the online application form.

  • The closing date was 9pm on Monday 20 November 2017.
  • Applicants should be available for interview 29 and 30 January 2018.

Please note that the two projects registered at Imperial will follow Imperial's recruitment processes and deadlines.

We use cookies to ensure that we give you the best experience on our website. By continuing to use this website, you are agreeing to our use of cookies on your device as described in our cookie policy. You can change your cookie settings at any time but parts of our site will not function correctly without them.